Rosenblatt Lowers Cerebras Price Target to $170

The news headline targets Cerebras, not AMD; therefore, its direct impact on AMD may be limited and indirect. AMD shares have experienced a sharp sell-off, falling 8.9% in the last 24 hours, with the RSI at 45.8 in neutral territory and the price trading just below the SMA20. The MACD is in negative territory but above the signal line, which may indicate weakening downside momentum. In the short term, the news is not expected to give a clear direction to AMD's price; the current technical picture is also indecisive. Therefore, I foresee a neutral trend over a 1-3 day perspective.

The news headline contains a price target cut related to Cerebras and is not directly related to TSM; therefore, its impact on TSM may be limited and indirect. TSM's technical picture is weak: the last close was 375.29, down 7.7% over 24 hours, the RSI is 41.96 in the neutral-to-weak zone, and the price is below the SMA20 (377.87), while the SMA50 (399.53) is clearly above. MACD is negative (-8.08) but above its signal line (-9.98), meaning downside momentum may be weakening somewhat. While the news impact is considered neutral in the short term, the current technical picture keeps a mild downside risk; however, it does not on its own generate a strong directional signal.

The news headline concerns Cerebras and does not directly target AVGO; therefore, its impact on the symbol may be limited and indirect. Following a sharp 11.7% decline in AVGO over 24 hours, the RSI has approached oversold territory at 29.7, which increases the likelihood of a short-term rebound buying. However, the price is clearly below the SMA20 and SMA50, and MACD is in negative territory; the trend is weak. Since the news has no direct impact, direction is uncertain; given current oversold conditions, a neutral view is more appropriate. Volatility is expected to continue in the short term.

The headline does not target NVDA directly but focuses on Cerebras, implying that any effect on NVDA will be indirect and limited. Nevertheless, NVDA is already under strong selling pressure: it has fallen more than 10% in the last 24 hours, its RSI sits at 36 indicating weak momentum, and the price remains below both the SMA20 and SMA50, undermining short‑term prospects. The MACD is in negative territory and only slightly above the signal line, so the recovery signal is weak. A downgrade of the AI‑chip sector could add further pressure on sector sentiment. Consequently, a 1‑3 day outlook highlights downside risk, but because the news’ direct impact is limited, the confidence level is moderate.